Phantomics said Tuesday that the company has received a medical device marketing authorization from the Thai Food and Drug Administration (TFDA) for its non-invasive cardiomyopathy diagnostic solution, Myomics.Myomics, launched by Phanthomics in 2020, is a service that non-invasively extracts dozens
JLK, a Kosdaq-listed medical AI company, said Wednesday that it had been granted a U.S. patent for its device and method for providing brain lesion information.The patent is a technology patent for a method that can accurately learn and analyze brain lesion areas in three-dimensional magnetic resona
Boehringer Ingelheim Korea said it has commenced a voluntary recall of select batches for Spiriva Respimat (ingredient: tiotropium bromide hydrate), its chronic obstructive pulmonary disease (COPD) and asthma medication.This medication is approved for use as a bronchodilator in the maintenance treat
Seoul National University Bundang Hospital (SNUBH) has been acknowledged for its efforts in catering to international patients, particularly following its second consecutive Global Health Accreditation (GHA) certification received in November of the previous year.The GHA certification recognizes the
In a recent media session organized by MSD Korea, a local professor shared insights regarding the efficacy of MSD's Lagevrio (ingredient: molnupiravir) in treating Covid-19, with a particular focus on high-risk groups.As the global community continues to recover from the pandemic, the Covid-19 virus
Bayer Korea's treatment for chronic kidney disease with type 2 diabetes, Kerendia (finerenone), will be covered by health insurance for adult patients starting next month.Kerendia is a first-in-class non-steroidal selective antagonist of the mineralocorticoid receptor, a novel mechanism of action th
Dong-A Pharmaceutical said Tuesday that it has launched a seven-day supply of Orthomol Vital M (for men) and Orthomol Vital F (for women), premium vitamin supplements from German nutraceutical company Orthomol.Orthomol Vital is a nutraceutical brand officially imported and sold in Korea by Dong-A Ph
President Yoon Suk Yeol said non-face-to-face medical treatment should be viewed from the perspective of developing the bio-medical industry, emphasizing that the government would pursue policies to attain administrative goals by fostering related industries rather than regulating them.President Yoo
For the sustainable growth of the domestic biopharmaceutical industry, the government must reform regulations to facilitate businesses’ investment, an industry leader said on Tuesday.To this end, the design of a simple, clear, and predictable drug price system is essential, and the legal status of t
GC Biopharma said Tuesday that it launched a 30-tablet version of its anti-inflammatory drug, Tak-Sen soft cap (naproxen).Tak-Sen is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) for relieving inflammation and general pain, such as headaches and muscle aches.According to GC Biophar
Patients with neuroendocrine tumors and their families are appealing to the National Assembly, urging a resolution to the issue of restricting the availability of domestic treatments for Lutathera. Lutathera treats neuroendocrine tumors that may manifest anywhere in the endocrine system, such as the
Rehabilitation therapy using augmented reality (AR) after shoulder surgery can improve postoperative shoulder pain and quality of life compared to conventional rehabilitation therapy, according to a study.Professor Shim Ga-yang of the Department of Physical and Rehabilitation Medicine at Kyung Hee U
VUNO said VUNO Med-DeepCARS, designed to predict cardiac arrest, has achieved a record-breaking number of new contracts and an increase in bed allocations on a monthly basis since its introduction to the market.Throughout January, VUNO has successfully forged agreements with more than 10 healthcare
AstraZeneca and Daiichi Sankyo have revolutionized the treatment of HER2-positive metastatic breast and gastric cancer by co-developing the anticancer drug Enhertu (trastuzumab deruxtecan). Notably, the DESTINY-Breast03 phase 3 clinical trial, which compared the effectiveness of the drug with Roche'
Daewoong Pharmaceutical said Tuesday that its U.S. partner, AEON Biopharma, has confirmed the safety and efficacy of Daewoong's botulinum toxin (BTX), ABP-450, through phase 2 clinical trials in cervical dystonia and preclinical results in post-traumatic stress disorder (PTSD).AEON Biopharma, a U.S.
The phase 2 clinical trial for preoperative adjuvant therapy, examining the Keytruda-GX-188E-GX-I7/NT-I7 triple combination in the treatment of HPV (human papillomavirus type)-positive head and neck cancer, initiated in 2022, is set to expand to include 56 patients this year.Genexine and NeoImmuneTe
As prescriptions for growth hormone injections have sharply increased, so have the number of reports on adverse events associated with growth hormone injections.Against this backdrop, a physician-turned-lawmaker recently called for attention to the risk of growth hormone abuse and misuse.Rep. Shin H
GC Wellbeing, a health/functional food manufacturer, said it signed a new export business agreement with YooYoung Pharmaceutical to enter the Chinese filler market.Under the accord, the two companies aim to develop, produce, market, and sell products specifically for the Chinese filler market, with
CHA Biotech, a Kosdaq-listed cell therapy company, said Monday that it has signed an agreement with Cancure, a U.S. immunotherapy developer, for a joint development of natural killer (NK) cell treatment to increase the anti-cancer effect of NK cell therapeutics.Under the agreement, CHA Biotech will
SK biopharmaceuticals announced its 2023 fourth quarter and annual financial results, highlighting significant revenue growth and a reduction in operating losses, thanks to increased sales of its epilepsy drug, cenobamate, and cost efficiency measures.The company's revenue for 2023 was 354.9 billion